NXGLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NXGLW
NEXGEL, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026
$5.80+0.21 (+3.76%)
Close on Oct 19, 2026
- Market cap
- $52.28M
- P/E (TTM)
- –
- Dividend yield
- –
Nexgel statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | Nexgel | Industry median |
|---|---|---|
| Market Cap | $56.54M | $230.55M |
| Enterprise Value | $57.00M | $202.97M |
| PS Ratio | 4.69 | 3.11 |
| PB Ratio | 11.42 | 3.14 |
Enterprise value
| Measure | Nexgel | Industry median |
|---|---|---|
| EV / Sales | 4.72 | 2.92 |
Income (trailing twelve months)
| Measure | Nexgel | Industry median |
|---|---|---|
| Revenue | $12.07M | $102.39M |
| Gross Profit | $4.23M | $60.36M |
| Operating Income | -$5.40M | -$4.31M |
| Pretax Income | -$6.05M | -$2.26M |
| Net Income | -$6.19M | -$6.57M |
| EBITDA | -$4.25M | -$1.98M |
| EPS (Diluted) | -$0.71 | -$0.07 |
Margins
| Measure | Nexgel | Industry median |
|---|---|---|
| Gross Margin | 35.1% | 55.1% |
| Operating Margin | -44.8% | -6.04% |
| Pretax Margin | -50.2% | -4.11% |
| Profit Margin | -51.3% | -10.5% |
| EBITDA Margin | -35.2% | -2.67% |
Returns
| Measure | Nexgel | Industry median |
|---|---|---|
| Return on Equity (ROE) | -128.6% | -19.2% |
| Return on Assets (ROA) | -34.2% | -13.3% |
| Return on Invested Capital (ROIC) | -91.0% | -4.11% |
| Return on Capital Employed (ROCE) | -45.0% | -9.07% |
Growth
| Measure | Nexgel | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 3.38% | 8.85% |
| Revenue Growth (3Y CAGR) | 77.3% | 7.08% |
| Revenue Growth (5Y CAGR) | 76.1% | 11.8% |
Balance sheet
| Measure | Nexgel | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $492.00K | $37.33M |
| Total Debt | $437.00K | $72.66M |
| Net Cash (Debt) | $55.00K | $3.92M |
| Net Cash Per Share | $0.01 | $0.28 |
| Equity (Book Value) | $4.95M | $57.36M |
| Book Value Per Share | $0.51 | $2.81 |
| Tangible Book Value | -$9.67M | $10.71M |
| Working Capital | -$8.27M | $54.64M |
Financial position
| Measure | Nexgel | Industry median |
|---|---|---|
| Current Ratio | 0.43 | 2.50 |
| Quick Ratio | 0.11 | 1.54 |
| Debt / Equity | 0.09 | 0.38 |
Cash flow (trailing twelve months)
| Measure | Nexgel | Industry median |
|---|---|---|
| Operating Cash Flow | -$3.21M | -$653.46K |
Efficiency
| Measure | Nexgel | Industry median |
|---|---|---|
| Asset Turnover | 0.67 | 0.59 |
| Inventory Turnover | 3.80 | 2.21 |
| Revenue Per Employee | $635.05K | $322.57K |
| Profits Per Employee | -$325.53K | -$51.88K |
| Employee Count | 19 | 185 |
Dividends and yields
| Measure | Nexgel | Industry median |
|---|---|---|
| Earnings Yield | -10.9% | -6.91% |
Shares
| Measure | Nexgel | Industry median |
|---|---|---|
| Shares Outstanding | 9,747,660 | 44,856,700 |
| Shares Change (YoY) | 14.6% | 3.35% |
| Shares Change (QoQ) | 14.4% | 0.27% |
| Float | 8,451,030 | 37,097,900 |
| Shares Held by Insiders | 13.3% | 10.6% |
| Shares Held by Institutions | 8.96% | 63.5% |
Scores
| Measure | Nexgel | Industry median |
|---|---|---|
| Altman Z-Score | -0.33 | 1.95 |
| Piotroski F-Score | 5 | 5 |
| Beneish M-Score | -3.41 | -2.64 |
Calculated by StockData from Nexgel's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.